Xenobiotics Shape the Physiology and Gene Expression of the Active Human Gut Microbiome  by Maurice, Corinne Ferrier et al.
Xenobiotics Shape the Physiology
and Gene Expression of the
Active Human Gut Microbiome
Corinne Ferrier Maurice,1 Henry Joseph Haiser,1 and Peter James Turnbaugh1,*
1FAS Center for Systems Biology, Harvard University, 52 Oxford Street, Cambridge, MA 02138, USA
*Correspondence: pturnbaugh@fas.harvard.edu
http://dx.doi.org/10.1016/j.cell.2012.10.052SUMMARY
The human gut contains trillions of microorganisms
that influence our health by metabolizing xenobi-
otics, including host-targeted drugs and antibiotics.
Recent efforts have characterized the diversity of
this host-associated community, but it remains
unclear which microorganisms are active and what
perturbations influence this activity. Here, we com-
bine flow cytometry, 16S rRNA gene sequencing,
and metatranscriptomics to demonstrate that the
gut contains a distinctive set of active microorgan-
isms, primarily Firmicutes. Short-term exposure to
a panel of xenobiotics significantly affected the phys-
iology, structure, and gene expression of this active
gut microbiome. Xenobiotic-responsive genes were
found across multiple bacterial phyla, encoding anti-
biotic resistance, drug metabolism, and stress
response pathways. These results demonstrate the
power of moving beyond surveys of microbial diver-
sity to better understand metabolic activity, highlight
the unintended consequences of xenobiotics, and
suggest that attempts at personalized medicine
should consider interindividual variations in the
active human gut microbiome.INTRODUCTION
Within the human gastrointestinal tract lies a diverse and abun-
dant group of microorganisms, the gut microbiota. Metagenom-
ics has enabled the analysis of the aggregate genomes of this
microbial community (the gut microbiome) (Human Microbiome
Project Consortium, 2012; Qin et al., 2010; Turnbaugh et al.,
2009a; Yatsunenko et al., 2012). However, most of these studies
are limited to a single phylogenetic marker gene (the 16S ribo-
somal RNA [rRNA]) or to shotgun sequencing community DNA.
Although powerful to determine community structure and meta-
bolic potential, these tools cannot be used to infer which bacte-
rial members of the community are active, damaged, or respon-
sive to a given compound. Due to these limitations, many
fundamental questions linking bacterial activity and identityremain unanswered, despite the importance of the gut micro-
biota for numerous metabolic processes.
One of these key processes is the resistance to and bio-
transformation of xenobiotics (compounds foreign to a living
organism), including host-targeted drugs and antibiotics (Haiser
and Turnbaugh, 2012). Although many clinically relevant drugs
aremetabolized by the gutmicrobiome, the specificmicroorgan-
isms responsible, the molecular mechanisms involved, and the
potential impact these compounds have onmicrobial physiology
and gene expression are often unknown. Studies linking bacterial
activity, gene expression, and identity are thus essential to iden-
tify the active component of the gut microbiota and its response
to common and clinically relevant stressors such as xenobiotics.
Single-cell methods, such as flow cytometry and fluores-
cence-activated cell sorting (FACS), have been used to charac-
terize the physiological structure of environmental and host-
associated microbial communities (Ben-Amor et al., 2005; Del
Giorgio and Gasol, 2008; Joux and Lebaron, 2000; Shapiro,
2000). From these studies, a general picture of bacterial physi-
ology has emerged in which cells from complex communities
can be classified according to their relative nucleic acid content
and the state of their membrane (Figure 1A). Relative nucleic acid
content is based on differences in the individual cell fluorescence
and light scatter signals after nucleic acid staining and is used as
a proxy of cellular activity. Generally, within an ecosystem, cells
with high nucleic acid content (HNA) are larger but also more
active, with higher metabolic activity and growth rates, than cells
with low nucleic acid content (LNA) (Gasol et al., 1999; Jellett
et al., 1996; Jochem et al., 2004), although the latter are not
completely inactive (Bouvier et al., 2007; Wang et al., 2009; Zub-
kov et al., 2004). The state of the bacterial membrane is another
crucial physiological indicator, as cells with a loss of membrane
polarity (DiBAC+ cells) or membrane integrity (Pi+ cells) are con-
sidered damaged or dying (Del Giorgio andGasol, 2008). In addi-
tion to these single-cell methods, metatranscriptomics (RNA
sequencing, RNA-seq) allows the direct analysis of the gene
expression profiles of the abundant metabolically active micro-
organisms in the human gut (McNulty et al., 2011; Rey et al.,
2010; Turnbaugh et al., 2009b, 2010). Here, we combine flow
cytometry, metatranscriptomics, and metagenomics to identify
and characterize the active subset of the gut microbiome and
to determine its short-term responses to xenobiotics.
By using these complementary techniques, we demonstrate
that the gut microbiota contains a distinctive active subsetCell 152, 39–50, January 17, 2013 ª2013 Elsevier Inc. 39
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Figure 1. The Human Gut Microbiota Is
Highly Active with Substantial Proportions
of Damaged Cells
(A) Cellular targets of the fluorescent dyes. The
nucleic acid dye Pi enters cells with compromised
membranes; DiBAC binds to intracellular lipid-
containing material of depolarized cells; and
SybrGreen stains the nucleic acids of all bacteria
irrespective of their membrane status, identifying
two clusters of cells: the low (LNA) and high (HNA)
nucleic-acid-containing cells.
(B) Average proportions of damaged cells (Pi+
and DiBAC+) and cells with a low (LNA) or high
nucleic acid content (HNA) in three unrelated
individuals (n = 5–10 samples/individual). Values
are mean ±SEM.
(C) SybrGreen and Pi dual staining in three unre-
lated individuals. Pi cells are in gray, and Pi+ cells
are in pink, with the HNA (solid) and LNA (stripes)
subsets indicated.
(D) Pi and DiBAC dual staining in the same indi-
viduals. Pi cells are in gray, and Pi+ cells are in
purple, with the DiBAC (stripes) and DiBAC+
(solid) fractions indicated.
Also see Figures S1 and S2 and Table S3.relative to the overall microbial community. The proportion of
each physiological fraction is comparable between unrelated
healthy individuals but displays marked temporal variations
within each person. Short-term exposure to xenobiotics not
only alters bacterial physiology but also significantly alters the
structure of the overall microbial community and each physiolog-
ical fraction, in addition to gene expression. These responses
may provide some clue as to which microorganisms, genes,
and pathways are involved in xenobiotic metabolism and as to
how the gut microbiota resists damage from these molecules.
In a larger sense, we provide a proof of principle for future studies
combining single-cell methods and metatranscriptomics to
investigate the response of human and environmental micro-
biomes to defined perturbations.
RESULTS
Most of theMicrobial Cells in the Human Gut Are Active,
but There Are Substantial Proportions of Damaged Cells
We determined the proportions of four physiological categories
in fresh fecal samples immediately after collection: cells with
loss of membrane integrity (Pi+), loss of membrane polarity
(DiBAC+), and with different relative nucleic acid content (high-
HNA and low-LNA, referred to here as the highly active and
less active subsets, respectively) (Figure 1A and Figures S1A
and S2A available online). In total, we assayed 21 fecal samples
from three unrelated individuals at 10 different time points
during 9 months (n = 5–10 samples/individual). Pi+ cells consti-
tuted 17.2% ± 2.1% of the gut microbiota (range across all indi-40 Cell 152, 39–50, January 17, 2013 ª2013 Elsevier Inc.viduals: 5.5%–41.1%). DiBAC+ cells were
27.4% ± 2.3% of the total community
(range: 15.4%–49.6%), and HNA cells
were 56.2% ± 3.5% (range: 25.3%–85.2%) (Figure 1B). No significant differences were observed
between individuals (p > 0.05, Kruskal-Wallis test). However,
we observed marked changes within each individual over time,
exceeding those foundwith either biological or staining technical
replicates (Figure S2C). These differences could not be attrib-
uted to the date or time of sample collection, the time since
the last antibiotic use, the time since or the composition of the
previous meal, or recent travel history (adjusted p value > 0.05,
MINE analysis) (Reshef et al., 2011). We quantified the size distri-
bution of HNA and LNA cells to test whether the increased fluo-
rescence observed in HNA cells could be explained by larger cell
size, due to division, stochastic variation, or interspecies differ-
ences; there was a trend toward increased size, but this was
not significant (1.216 ± 0.092 mm versus 0.961 ± 0.002 mm,
respectively; p > 0.05, Mann-Whitney test). Thus, on average,
more than half of the gut microbiota had increased metabolic
activity not solely attributable to increased cell size, whereas
nearly one-third could be considered damaged.
Firmicutes Dominate the Active and Damaged Subsets
of the Gut Microbiota
We combined FACS with 16S rRNA gene sequencing methods
to identify cells within each physiological fraction (referred to
here as FACS-seq; Figure S1B and Table S1A). Community
membership (presence/absence) was consistent across all
physiological categories, with 99/100 of the most abundant
species-level bacterial operational taxonomic units (OTUs) and
15/15 of the abundant genera (R1% 16S rRNA sequences
in at least one sample) common to all groups (Figure 2A).
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Figure 2. The Human Gut Microbiota Contains a Distinctive Active Subset
(A) Number of abundant genera (relative abundanceR1% in at least one sample) found in the Pi+, DiBAC+, LNA, and HNA fractions, as compared to the overall
unsorted community (control). Values are mean ±SEM.
(B) Unweighted UniFrac clustering of community membership across each subgroup. Samples are labeled by individual in (B)–(D): red (individual A), green
(individual B), and blue (individual C).
(C) Comparisons of microbial community structure by using the Bray-Curtis distance metric. The first principal component is shown across each subgroup and
individual.
(D) The active and damaged subsets of the gut microbiota are distinctive from the overall unsorted community (control). UPGMA clustering based on Bray-Curtis
distance is shown on the left: replicate samples are collapsed into wedges, and three outliers have been removed (see Figure S3A for the full tree). The relative
abundance of the major bacterial families in the gut microbiota: Firmicutes (blue), Bacteroidetes (orange), and Actinobacteria (Bifidobacteriaceae, purple).
Remaining taxa have been grouped into ‘‘Other.’’
Also see Figures S3 and S4 and Tables S1, S4, and S5.We also observed clear interindividual differences in bacterial
community membership, regardless of physiological status
(Figure 2B).
The relative abundance of species-level OTUs in all individuals
was altered in highly active cells (HNA), relative to either LNA
cells or the overall bacterial community (Figures 2C, 2D, and
S3A). HNA cells were significantly enriched for Clostridiales (Fir-
micutes phylum, 90.8% ± 1.7% versus 34.8% ± 7.2%) and
depleted for Bacteroidales (4.6% ± 1.7% versus 62.8% ±
7.0%), relative to the overall fecal microbiota (p < 0.05, Student’s
t test). By contrast, LNA cells were significantly enriched forBifidobacteriales relative to the overall community (18.0% ±
0.2% versus 1.4% ± 0.5%; p < 0.001, Student’s t test). The
differences between the HNA and LNA fractions could not be ex-
plained by increased genome size or rRNA copy number, as the
Clostridiales reference genomes in our database were signifi-
cantly smaller than the Bacteroidales (3.22 ± 0.15 versus
4.37 ± 0.18 Mbp; p < 105, Student’s t test) and had similar
numbers of 16S rRNA genes (2.36 ± 0.25 versus 2.15 ± 0.40;
p > 0.05, Student’s t test). However, Bifidobacteriales did exhibit
smaller genomes and fewer rRNA genes than the Clostridiales,
potentially contributing to their enrichment in the LNA fractionCell 152, 39–50, January 17, 2013 ª2013 Elsevier Inc. 41
(2.27 ± 0.08 versus 3.22 ± 0.15Mbp; p < 105; 1.58 ± 0.29 versus
2.36 ± 0.25 16S rRNA genes; p < 0.05, Student’s t tests).
As further validation, cultured gut isolates from the five domi-
nant bacterial phyla were analyzed during in vitro growth, con-
firming that all of the strains could be efficiently stained with
SybrGreen and that the proportions of damaged cells signifi-
cantly increased for each strain following heat or ethanol treat-
ment (Table S3A).
To further explore these trends, we employed LEfSe, a tool
for metagenomic biomarker discovery (Segata et al., 2011).
Taxa at multiple phylogenetic depths were found at significantly
higher relative abundance within each physiological fraction
relative to the others (Table S4A and Figure S3B). Bacteroidetes
(Bacteroides), Bifidobacteriales (B. adolescentis and B. longum),
and Lachnospiraceae (Roseburia faecis) were enriched in the
less active component of the gut microbiota (LNA). Specific
groups within the Firmicutes, such as the Ruminococcaceae
and certain Clostridiales (Blautia sp. and Coprococcus sp.),
were associated with the HNA, Pi+, and DiBAC+ fractions, sug-
gesting that members of this diverse phylum vary in their activity
levels and level of membrane damage. Overall, the damaged
subset of the gut microbiota (Pi+ and DiBAC+ cells) shared
a similar community structure to the more active (HNA) fraction
(Figures 2C, 2D, and S3A).
Together, these results indicate that the fecal microbiota
harbors a distinctive active subset enriched for Clostridiales.
The concordance between the HNA and damaged subsets
suggests that these cells are both metabolically active and are
rapidly turning over, whereas other members of the community
are less active; however, we cannot entirely exclude the possi-
bility that Clostridiales are more sensitive to oxygen exposure
during sample collection. To confirm that single cells from
human fecal samples can be both active and damaged, we
quantified the overlap between the Pi+ and HNA populations
by using a dual-staining approach; 7.64% ± 1.45% of total
cells were both Pi+ and HNA, representing 30.63% ± 4.94%
of the total Pi+ cells (Figure 1C). Also, Pi and DiBAC dual
staining revealed that cells with damaged membrane integrity
were a subset of the population of cells with altered polarity:
94.0% ± 4.9% of Pi+ cells were also DiBAC+ (Figure 1D).
We validated these findings by using metatranscriptomics
(RNA-seq) coupledwithmetagenomic sequencing of community
DNA at two time points from the same individuals (7.3 ± 1.6
million RNA and 7.0 ± 2.3million DNA sequencing reads/sample;
Table S1B). Most of the gut microbiome was transcriptionally
active; the majority of the observed reference genomes were
found in the paired RNA-seq and community DNA from each
individual (87.7% ± 3.0%; n = 6), whereas all of the 185 most
abundant genomes were shared (>121 RPKM on average).
However, gene expression profiles from all individuals before
and after 4 hr of incubation in rich medium under anaerobic
conditions were distinct from gene abundance (Figure S4). Con-
sistent with our FACS-seq results, genomes from the Firmicutes
phylum exhibited significantly higher-than-expected expression
relative to the Bacteroidetes (3.9 ± 0.6 versus 1.7 ± 0.4 fold
change, p < 0.01, Student’s t test). In total, 15 different Firmi-
cutes taxonomic groups, but no Bacteroidetes, had R4-fold
higher gene expression relative to abundance (Table S5A), while42 Cell 152, 39–50, January 17, 2013 ª2013 Elsevier Inc.2,719 gene clusters had significantly altered expression relative
to abundance (Table S5B; p < 0.01, >5-fold change). Rank
products analysis identified 985 gene clusters with significantly
decreased expression relative to abundance (Table S5C;
FDR < 0.1, >10-fold change); these were significantly biased
toward Bacteroidetes over Firmicutes (720 versus 162; p <
0.0001, c2 test). Combined, these results are consistent with
the hypothesis that a distinctive subset of microorganisms, en-
riched for Firmicutes, tends to dominate the active fraction of
the gut microbiome.
Antibiotics, but Not Host-Targeted Drugs, Rapidly
Influence Microbial Physiology
Having defined the compositional, interindividual, and temporal
variations in the active microbiome, we sought to determine the
response of this distinctive subset to short-term perturbations.
In particular, exposure to xenobiotics such as antibiotics and
host-targeted drugs seemed likely candidates given their long-
lasting influence on the composition of the gut microbiota
(Dethlefsen and Relman, 2011; Jernberg et al., 2010). We thus
conducted incubations with a panel of 14 xenobiotics (six host-
targeted drugs and eight antibiotics; Figure S1C and Table S2)
and at lower pH (pH 4, pH 5, and pH 6) to contrast the effects
of xenobiotics with those from simple environmental perturba-
tions. Ethanol was the xenobiotics vehicle and did not result
in significant changes of bacterial physiology relative to un-
amended samples (p > 0.05, Dunn’s test), whereas low pH signif-
icantly increased the proportions of damaged cells (Figure 3).
Antibiotics exposure significantly increased the proportions of
damaged cells (Figure 3). Averaged across all tested compounds
and individuals, DiBAC+ cells increased from 32.7% ± 3.8% to
43.8% ± 2.7%, and Pi+ cells increased from 11.5% ± 3.7% to
22.9% ± 2.8%, when comparing ethanol controls to antibiotic
treatments, respectively (p < 0.05, Wilcoxon rank-sum test).
The proportion of HNA cells was not significantly altered by anti-
biotics (51.5% ± 7.4% [control] versus 51.9% ± 1.8%; p > 0.05,
Wilcoxon rank-sum test); this was also the case for total cell
abundance (1.26 3 1011 ± 2.34 3 1010 [control] versus 1.12 3
1011 ± 8.18 3 109 cells.ml1), suggesting a rapid increase in
membrane damage without complete lysis.
Substantial temporal variation in antibiotic-induced cell
damage was observed (Figure 4 and Table S3B). These varia-
tions could not be attributed to the date or time of sample collec-
tion, the time since or the composition of the previous meal, or
recent travel history (p > 0.05, MINE analysis), but we observed
significant associations with the baseline physiology and micro-
bial community structure of each sample. The proportion of
depolarized cells (DiBAC+) at the time of sample collection was
significantly associated with the average %DiBAC+ cells fol-
lowing antibiotic treatment (p < 0.05, Spearman rank correla-
tion). Also, the baseline abundances of the Parabacteroides
and Escherichia genera were inversely associated with the
mean proportion of Pi+ cells following antibiotic treatment (n =
2–3 time points/individual; MIC > 0.98, adjusted p value < 0.05,
MINE analysis of all abundant bacterial genera [average relative
abundance > 1%]).
Altogether, 75% of the antibiotics tested had significant
impacts on cell damage (Table S3B). However, ampicillin was
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Figure 3. Antibiotics, but Not Host-Targeted Drugs, Alter Microbial
Physiology
Top to bottom: average proportions of cells with loss of membrane integrity,
altered polarity, and high levels of activity across three unrelated individuals,
determined after incubations with xenobiotics. Control incubations consisted
of unamended BHI medium, BHI medium with the drug vehicle (ethanol), and
low pH. Treatments with a significant impact relative to controls are noted (p <
0.05, Dunn’s test). Values are mean ±SEM.
Also see Figure S5 and Tables S2 and S3.the only compound that consistently increased the proportion of
Pi+ cells when averaged across all individuals and all time points
(Figure 3; p < 0.05, Dunn’s test), suggesting that antibiotics tar-
geting cell wall synthesis in Gram-positive bacteria may consis-
tently induce membrane damage. This was further tested with
another cell wall synthesis inhibitor specific to Gram-positive
bacteria (vancomycin) and a cell membrane disrupter specific
to Gram-negative bacteria (polymyxin B; n = 3 individuals attwo time points; Table S2). Both cell wall synthesis inhibitors
significantly induced cell damage, whereas no significant effects
were observed following exposure to polymyxin B (Figure 5A).
Analysis of microbial community structure before and after
exposure to antibiotics revealed significant differences, although
they were minor relative to interindividual and temporal varia-
tions (Figure S5A). ANOVA and LefSe-based comparisons of
species-level OTUs among all eight treatments revealed multiple
OTUs and taxonomic groups with significantly altered relative
abundance following antibiotic treatment (Tables S4B and
S4C); 90% of the affected OTUs were Firmicutes. These antibi-
otic-responsive OTUs were affected in unique ways by different
classes of compounds; for example, an OTU representing Fae-
calibacterium prausnitzii increased 4.5-fold after ampicillin treat-
ment but decreased after exposure to the other compounds.
Repeated administrations of ampicillin to fecal samples col-
lected from one individual revealed that it significantly reduced
the expansion of Enterobacteriales during the 4 hr incubation
(13.7% ± 4.3% [vehicle control] versus 0.6% ± 0.2% [ampicillin],
p < 0.05, Kruskal-Wallis test; Figure S5B).
In contrast, the host-targeted drugs did not exhibit a
pronounced impact on microbial physiology, even when tested
at high concentrations (100-fold concentration increase, p >
0.05, Wilcoxon rank-sum test). Subtle changes in community
structure were observed when performing LefSe analysis across
all six treatments (Table S4C), but samples were mainly still
grouped by individual and not by treatment (Figure S5C). Incuba-
tions at low pH significantly modified community structure,
increasing the relative abundance of Clostridiales (56.4% ±
1.2% [pH 4]), relative to the control (37.2 ± 10.0 [pH 7]; p <
0.01, Student’s t test of pH 4 versus pH 5–7).
Finally, we sought to determine whether exposure to xenobi-
otics or low pH could alter the structure of the active or damaged
subsets of the gut microbiota. Fecal samples were collected and
exposed to ampicillin, digoxin, or low pH for 4 hr prior to FACS-
seq. The results confirmed our original characterization of the
active and damaged gut microbiota, with an increased abun-
dance of Clostridiales in the active and damaged subset, in addi-
tion to a higher level of Bacteroidales and Bifidobacteriales in the
less active fraction (Figure 5B). Furthermore, LefSe analysis re-
vealed that low pH and ampicillin exposure resulted in significant
changes to the active and damaged gut microbiota (Table S4D),
namely an increased relative abundance of members of the
Bacteroidetes phylum. Digoxin also led to a significantly higher
relative abundance of the Faecalibacterium genus (Firmicutes
phylum) in the Pi+ subset (15.0% ± 0.9% after digoxin treatment
versus 10.5% ± 1.2% in controls; Table S4D). Together, these
results emphasize that, despite shared features of the active
and damaged gut microbiota between healthy individuals, it
can be rapidly altered following exposure to xenobiotics.
Short-Term Exposure to Xenobiotics Affects
Community-wide Gene Expression
In order to more comprehensively characterize the influence of
xenobiotics on the active gut microbiome, we tested for changes
in community-wide gene expression following xenobiotics expo-
sure. RNA-seq profiles were obtained after the same 4 hr incuba-
tions with host-targeted drugs, antibiotics, vehicle controls, andCell 152, 39–50, January 17, 2013 ª2013 Elsevier Inc. 43
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Figure 4. The Physiological Response of Microbial Communities to
Antibiotics Varies over Time within Each Individual
Top to bottom: proportions of cells with loss of membrane integrity, altered
polarity, and high levels of activity after antibiotics exposure. Values for vehicle
controls are indicated with asterisks. When visible, error bars represent
staining replicates. Values are mean ±SEM.
Also see Figure S5 and Tables S2 and S3.
44 Cell 152, 39–50, January 17, 2013 ª2013 Elsevier Inc.low pH used for the analysis of microbial physiology and
community structure (Figures S1C and S1D and Table S1B;
565 ± 142 thousandmRNA sequencing reads/sample). To obtain
a high-level view of the transcriptional response to xenobiotics,
we tallied the number of normalized counts assigned to each
KEGG metabolic pathway and higher-level category. In general,
the treatment and control samples shared a similar distribution of
pathways (Figure S6A; note, all correlations were >0.9) and cate-
gories (Figure 6A). Transcriptional profiles were most similar
when from the same individual and the same time point.
However, clear deviations from this pattern occurred after expo-
sure to tetracycline and macrolide antibiotics that inhibit transla-
tion (Figure 6B). All three treatments resulted in an increased
expression of genetic information processing genes (e.g., tran-
scription and translation; 24.8% ± 0.4% versus 32.8% ± 0.7%
of assignments in controls compared to treatments, p < 105,
Student’s t test). Analysis of KEGG module and pathway abun-
dance with HUMAnN and LEfSe confirmed and extended these
trends; antibiotics induced the expression of modules for tRNA
biosynthesis, translation, vitamin biosynthesis, and phosphate
transport, whereas host-targeted drugs induced modules for
membrane transport, the pentose phosphate pathway, and
xenobiotic metabolism/biodegradation (Tables S4E and S4F).
A complementary analysis using the COG ontology (Tatusov
et al., 2000) and the ShotgunFunctionalizeR package (Kristians-
son et al., 2009) revealed qualitatively similar clustering within
each individual (Figure S6B), which was quantitatively confirmed
by comparing Spearman distancematrices constructed for each
individual (p < 0.05, Mantel test). A total of 832 orthologous
groups were identified with significantly different expression
levels between the treatments and controls (Table S6). We
then clustered the transcriptional responses to the 14 xenobi-
otics, revealing four major response groups (Figure 7). Drugs
from the same class were nearest neighbors, including the
cardiac glycosides (digoxin and digitoxin) and the tetracyclines
(doxycycline and tetracycline), but the fluoroquinolones (cipro-
floxacin and norfloxacin) resulted in divergent responses. Expo-
sure to antibiotics resulted in a more dramatic transcriptional
response relative to host-targeted drugs (146 ± 29 versus 67 ±
17 upregulated COGs and 97 ± 13 versus 38 ± 8 downregulated
COGs; p < 0.05, Student’s t test). A subset of these groups was
consistently differentially expressed across the majority of com-
pounds, potentially representing conserved pathways for re-
sponding to xenobiotics or environmental stress (Extended
Experimental Procedures).
Xenobiotics Induce the Expression of Genes for Drug
Resistance and Metabolism
We then searched for gene clusters affected by exposure
to xenobiotics (Figure S1D). In total, we identified 1,728 gene
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Figure 5. Antibiotics Targeting Cell Wall
Biosynthesis Consistently Increase Cell
Damage and Change the Structure of the
Active and Damaged Gut Microbiota
(A) Average proportions of cells with loss of mem-
brane integrity, altered polarity, and high levels of
activity following exposure to antibiotics targeting
the bacterial cell wall and membrane (two time
points/individual). Values are mean ±SEM.
(B) Changes to the highly active (HNA), less active
(LNA), and damaged (Pi+) gut microbiota following
exposure to ampicillin, digoxin, and low pH. Each
experiment represents FACS-seq analysis of
samples from a single individual with or without
treatment. Bars represent the average across all
technical replicates (n = 2–3 replicates).
Also see Figure S5 and Tables S1, S2, and S4.clusters differentially expressed after antibiotics exposure
(p value < 0.05, >2-fold change; Tables S7A–S7H) and 328 after
exposure to host-targeted drugs (Tables S7I–S7N). A more strin-
gent rank products analysis revealed 350 gene clusters with
significantly decreased expression after the addition of antibi-
otics (FDR < 0.1; Table S7Q); 64.3% (225) were in response
to ampicillin, and 88.9% of those (200) were attributed to the
Bifidobacterium and Collinsella genera, isolates of which are
sensitive to b-lactam antibiotics (Le Blay et al., 2007).
These gene-centric results, combined with our metabolic
pathway, module, and functional group analyses, provide insight
into the microbial genes and genomes involved in drug resis-
tance and metabolism in the human gut. For instance, recent
studies of cultured gut bacteria have demonstrated that, in
addition to inhibiting their intended target, antibiotics induce
metabolic stress (Kohanski et al., 2007), a process related to
proton motive force (Lee and Collins, 2012). Our results suggest
that these processes also occur within the intact human gut
microbiota; exposure to antibiotics induced the expression of
key genes affecting stress response (e.g., cell death regulator
MazG and heat shock regulator protein HspR), proton motiveCell 152, 39–5force, antibiotic resistance (e.g., tetracy-
cline resistance protein and MATE efflux
family protein), and phage induction
(Tables S7A–S7H and Extended Experi-
mental Procedures).
Our data also provide multiple candi-
date genes for the microbial biotransfor-
mation of xenobiotics (Tables S6 and
S7). For example, the cardiac glycosides
digoxin and digitoxin undergo microbial
reduction (Lindenbaum et al., 1981;
Magnusson et al., 1982), and both com-
pounds induced reductases, transcrip-
tional regulators, and small-molecule/
sugar transporters (Tables S7I–S7N and
Extended Experimental Procedures).
Nizatidine, known to undergo N-oxide
bond cleavage (Sousa et al., 2008),
induced the expression of drug/metabo-lite transporters and enzymes acting on nitrogen bonds. Phenac-
etin, an aromatic compound that undergoes N-deacetylation
(Smith and Griffiths, 1974), uniquely induced the expression
of genes annotated as aromatic ring-cleaving dioxygenases
and acylaminoacyl-peptidases. Sulfasalazine, known to undergo
azo reduction (Sousa et al., 2008), induced the expression of
gene clusters annotated as encoding thioredoxins and nitrate
reductases. Finally, tetramisole, which undergoes a thiazole
ring opening and disulfide bond formation (Sousa et al., 2008),
induced the expression of sulfoxide reductases, genes involved
in disulfide bond formation, and sulfate transport systems.
DISCUSSION
Moving beyond DNA-Based Measurements of Microbial
Communities
During the last few years, the wealth of information describing
the organismal and genetic diversity found in the complex
microbial communities colonizing different body habitats has
allowed us to better assess the key factors influencing commu-
nity assembly and metabolic potential. However, these largely0, January 17, 2013 ª2013 Elsevier Inc. 45
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Figure 6. Impact of Xenobiotics on the Expression of KEGG Categories
Expression levels of genes assigned to high-level KEGG categories following short-term exposure to xenobiotics.
(A) The percentage of normalized counts assigned to each category is shown for the 14 treatments and their vehicle controls.
(B) Principal component analysis of KEGG category expression levels for the 14 treatments and controls. The mean expression profile for each group was
clustered by using the ‘‘princomp’’ function in Matlab.
Also see Figure S6 and Tables S2, S4, and S7.DNA-based studies have provided limited insight into the meta-
bolic activity of their microbial affiliates and their molecular
responses to common perturbations, such as xenobiotics expo-
sure. Through a combination of flow cytometry, 16S rRNA gene
sequencing, and metatranscriptomics, we characterized the
active subset of the human gut microbiome and its response
to a common and clinically relevant perturbation: exposure to
host-targeted drugs and antibiotics.
Single-cell methods have allowed the description of bacterial
physiology in several ecosystems and have linked physiological
categories to different levels of activity and biomass (Davey and
Winson, 2003; Del Giorgio and Gasol, 2008; Wang et al., 2009).
We successfully applied this approach to determine the physi-
ology of cells in the gut microbiota, presenting evidence for
four distinct physiological categories ranging from highly active
to severely damaged cells. More than half of the gut microbiota
can be considered as highly active, with HNA proportions
comparable to values from very productive aquatic systems,
such as estuaries and marshes (Bouvier et al., 2007). This high
level of activity is likely sustained by our regular dietary input of
nutrients and the ability of the gut microbiota to metabolize
glycoproteins from saliva, gastric juice, and mucus (Blaut, 2011).
FACS-seq analysis of cells from each physiological category
revealed that the active subset was enriched for Clostridiales,
and the less active subset was enriched for Bifidobacteriales,
which is consistent with recent reports using complementary
methods (Gosalbes et al., 2011; Peris-Bondia et al., 2011) and
is supported by our comparisons of gene expression and abun-
dance. Our results suggest that the composition of the active
gut microbiota cannot simply be explained by methodological
biases in staining, an increased rate of cell division, larger cell
or genome size, or more copies of the 16S rRNA gene. In aquatic
ecosystems, numerous studies have demonstrated that the HNA
cell population has an increased rate of metabolic activity (e.g.,46 Cell 152, 39–50, January 17, 2013 ª2013 Elsevier Inc.labeled leucine or thymidine uptake and observation of dividing
cells [Bouvier and Maurice, 2011; Jellett et al., 1996; Wang
et al., 2009]). Similar studies on the gut microbiota are needed
to determine the extent to which these trends are conserved in
host-associated microbial communities.
In addition to high proportions of metabolically active cells, we
also report that one-third of the gut microbiota is composed
of damaged cells with impaired membrane polarity (DiBAC+).
More severely damaged cells with compromised membrane
integrity (Pi+) constitute less than one-quarter of the total com-
munity, which is consistent with previous reports (Ben-Amor
et al., 2005). These findings support a view of the human gut
as an ecosystem harboring productive bacterial communities,
with a surprising level of temporal variation in activity and cell
damage given the overall stability of strong drivers of bacterial
physiology, such as temperature, pH, and nutrient availability
(Blaut, 2011; Walter and Ley, 2011). More work is needed to
identify the factors responsible for these temporal dynamics,
e.g., dietary changes, phage exposure, bile acids, host immu-
nity, or other ill-defined factors.
Ecological Tradeoffs between Activity Level and Cell
Damage
Our FACS-seq analysis demonstrates that both the active and
damaged subsets are enriched for Clostridiales, suggesting
that environmental stressors may more readily influence these
groups. Multiple observations support this hypothesis: the
majority of the species-level OTUs significantly impacted by
antibiotic treatment were Clostridiales; antibiotics exposure
increased the overall level of gene expression of the Clostridiales
(185,500 ± 41,386 versus 489,362 ± 59,430 RPKM in controls
relative to antibiotic treatments; p < 0.001, Student’s t test);
the most consistent physiological responses were after expo-
sure to antibiotics targeting Gram-positive bacteria (of which
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Figure 7. Short-Term Exposure to Antibiotics and Host-Targeted
Drugs Results in Altered Community-wide Gene Expression
COGs up- or downregulated after exposure to xenobiotics are labeled red and
blue, respectively (adjusted p value < 0.01, AIC < 300). COGs with significantly
different expression between controls collected on separate days were
excluded. Treatments and COGs were clustered by using the ‘‘clusterGram’’
function in Matlab. The four major treatment groups are noted by colored
boxes on top of the heatmap.
Also see Figure S6 and Tables S2, S4, S6, and S7.Clostridiales are the dominant member); and dual-staining re-
vealed that up to one-third of Pi+ cells could also be HNA cells.
Together, these findings prompt the hypothesis that members
of the gut microbiota may inhabit distinct ecological niches,
defined not only by physical location and resource utilization
but also by their level of metabolic activity. A similar hypothesis
has been proposed for pathogens, wherein metabolically active
cells exhibit increased susceptibility to antibiotics (Levin and
Rozen, 2006; Martı´nez and Rojo, 2011). Studies of genetically
tractable commensal gut microorganisms in vitro and in mouse
models will be necessary to test to what degree differing levels
of metabolic activity influence bacterial fitness when controlling
for differences in diet, host genotype, and microbial community
structure.
Implications for Personalized Medicine
The magnitude of the physiological response to each xenobiotic
varied substantially between individuals and over time, although
antibiotics generally had a greater impact than host-targeted
drugs. Our results are consistent with multiple, not necessarily
mutually exclusive, mechanisms that could be responsible for
these variations. First, we detected associations between the
composition of each individual’s gut microbiota and the extent
of cell damage, which is consistent with previous studies
demonstrating that bacterial susceptibility to antibiotics can be
highly species- or even strain-specific (Mortimer et al., 2000;
Novo et al., 2000; Wickens et al., 2000). Second, the degree ofresponse could be driven by variations in the prevalence and/or
expression of xenobiotic-induced genes impacting drug metab-
olism, small-molecule transport, antibiotic resistance, stress
response, and/or the production of protective molecules.
Elucidating the underlying mechanisms for xenobiotic resis-
tance and metabolism in the active human gut microbiome will
not only provide insight into host-microbial interactions and
biochemistry but may also provide indications for unexplained
patient-to-patient variations in drug efficacy and toxicity. Our
results provide a view of the degree and consistency of the
microbial response to a panel of xenobiotics. As expected, anti-
biotics had the strongest effects, whether assessing physiology,
community structure, or gene expression, the latter being sig-
nificantly affected by all of the tested xenobiotics. In particular,
cell wall synthesis inhibitors targeting Gram-positive bacteria
consistently increased cell damage, whereas compounds inhib-
iting translation dramatically altered gene expression profiles.
Surprisingly, we observed a divergent transcriptional response
to the fluoroquinolones, despite the same mechanism of action,
prompting more studies to determine whether these closely
related compounds differ in their ability to elicit off-target effects
or in their spectrum of susceptible gut microorganisms.
A Metagenomic Perspective of Drug Resistance and
Metabolism
Our results also emphasize the many impacts of antibiotics on
the gut microbiome, including the induction of antibiotic resis-
tance genes, stress response pathways, and bacteriophage
elements. It will be important to perform time series experi-
ments to determine how the short-term alterations to microbial
physiology and gene expression described here translate into
long-term changes to microbial community structure following
exposure to antibiotics (Dethlefsen and Relman, 2011; Jernberg
et al., 2010).
Although >40 host-targeted drugs are modified by members
of the gut microbiota, with important implications for drug
efficacy and toxicity, the microorganisms and the genetic
machinery involved often remain unknown (Haiser and Turn-
baugh, 2012). These results show that, despite minimal short-
term effects on microbial physiology or community structure,
all six host-targeted drugs tested resulted in significant changes
to the genes expressed by the human gut microbiome. This
catalog of xenobiotic-induced microbial genes includes candi-
date genes for drug import, metabolism, and transcriptional
regulation, providing the basis for follow-up studies aimed at
confirming their predicted activities and determining their distri-
bution among members of the human gut microbiota. It will be
important to measure the concentration of these host-targeted
drugs along the length of the gastrointestinal tract in humans
or animal models, coupled to a detailed profile of the concentra-
tion and activity of the microbial enzymes of interest. Finally,
these results raise the question as to whether exposure to
xenobiotics has provided enough selective pressure to lead to
microbial systems fine-tuned for specific drugs, or whether the
observed responses represent crosstalk between xenobiotics
and systems evolved to respond to other natural targets.
Detailed structure-function analyses, coupled to an in-depth
characterization of the endogenous compounds produced byCell 152, 39–50, January 17, 2013 ª2013 Elsevier Inc. 47
the host and the gut microbiota, will be necessary to answer
these questions.
The integrated characterization of the host, microbial, and
environmental factors governing the response of the gut
microbiome to xenobiotics could ultimately be used for the
design of diagnostic tests predicting drug pharmacokinetics
or therapeutic interventions. At aminimum, these results empha-
size that, in order to understand the ultimate fate of xenobiotics
and their impact on human health, it is important to consider
their intended, or often unintended, effects on the active gut
microbiome.
EXPERIMENTAL PROCEDURES
Sample Collection
All human studies were done under the guidance of the Harvard Committee on
the Use of Human Subjects in Research (Protocol F18510). The three recruited
unrelated healthy subjects were free of gastrointestinal disorders and did not
use antibiotics during the course of the experiment. Additional subject infor-
mation is provided in the Extended Experimental Procedures. Fresh fecal
samples (n = 5–10 samples/individual) were immediately diluted 1:10 in
PBS, centrifuged at 700 g for 1 min, and transferred to an anaerobic chamber.
Bacterial Physiology
Bacterial physiology was assessed with three fluorescent stains (Figure 1A):
propidium iodide (Pi), bis-(1,3-dibutylbarbituric acid)trimethine oxonol
[DiBAC4(3)], and SybrGreen I, allowing the observation of cells with loss of
membrane integrity and membrane polarity and with distinct nucleic acid
content, respectively (Del Giorgio and Gasol, 2008). Cells were stained in the
dark under anaerobic conditions after testing sample preparation and staining
conditions (Figure S2B). The percentages of Pi+, DiBAC+, LNA, and HNA cells
were calculated relative to the total bacterial counts obtained by SybrGreen I
staining.
FACS of Bacterial Physiological Categories
Fecal samples from the same individuals were sorted on a MoFlo cytometer
equipped with a 488 nm excitation and 530 nm band pass filter for detection
(Becton Dickinson). For each individual, we sorted 50,000 bacterial events of
each physiological category (Figure S1B) and processed them according to
published protocols, with three consecutive freeze-heating (100C) cycles in
liquid nitrogen and a thermocycler (Guillebault et al., 2010), before PCR ampli-
fication. We also determined the average size of sorted HNA and LNA bacteria
in all individuals by using a ‘‘Multisizer 3’’ Coulter Counter (20 mm aperture)
according to the manufacturer’s guidelines (Beckman Coulter).
16S rRNA Gene Sequencing and Analysis
Samples were kept at80C until DNA extraction with the PowerSoil bacterial
DNA extraction kit (MoBio, Carlsbad, CA). The V4 region of the 16S rRNA gene
was PCR amplified in triplicate, and the resulting amplicons were cleaned,
quantified, and sequenced with custom barcoded primers on the Illumina
HiSeq platform according to published protocols (Caporaso et al., 2011,
2012) (Table S1A). Sequences were analyzed with the QIIME software
package (Quantitative Insights Into Microbial Ecology) (Caporaso et al.,
2010), in addition to custom Perl scripts to analyze a (within sample) and
b (between sample) diversity. LEfSe analysis (Segata et al., 2011) and OTU
significant tests by ANOVA were performed on filtered data sets; rare OTUs
with <1,000 sequence counts or found in <10 samples were excluded.
Ex Vivo Incubations with Xenobiotics
All incubations took place for 4 hr under anaerobic conditions, in the dark, and
at 37C. Fresh fecal samples from the same individuals were diluted 1:10 in
freshly prepared liquid BHI (pH 7; Becton Dickinson). We tested six host-tar-
geted drugs and eight antibiotics (Figure S1C and Table S2). Control incuba-
tions consisted of BHI with or without the drug vehicle (ethanol). Bacterial
physiology, community structure, and gene content were assessed as previ-48 Cell 152, 39–50, January 17, 2013 ª2013 Elsevier Inc.ously described, prior to the incubations. Following the incubations, we deter-
mined bacterial physiology, community structure, and gene expression
patterns. We set the amount of each xenobiotic (10 mg.ml1) to be near to or
lower than the estimated level remaining in the small intestine and colon
(Baselt, 2008; Raaflaub and Dubach, 1975; Somogyi et al., 1995).
RNA-Seq Sample Preparation and Analysis Pipeline
Methods for microbial mRNA sequencing and analysis were as previously
described (McNulty et al., 2011; Rey et al., 2010; Turnbaugh et al., 2009b,
2010) (see Figure S1D and Extended Experimental Procedures).
Statistical Analysis
Data are expressed as mean ±SEM, unless otherwise noted. Statistics were
performed by using GraphPad Prism (v. 5), Microsoft Excel (v. 14), and the
MINE software package (Reshef et al., 2011). Significance was accepted at
p < 0.05, unless otherwise noted.
ACCESSION NUMBERS
RNA-seq data are deposited in the Gene Expression Omnibus (GEO) database
with the accession number GSE38151; 16S rRNA gene sequencing reads are
deposited in MG-RAST with the accession number 1319.
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figures, and seven tables and can be found with this article online at http://
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